Pure Global

"Weibao" Prismavrex Continuous Fluid Management and Renal Replacement Therapy Integrated System - Taiwan Registration 7541c691f79e25e53533f90c5a976be7

Access comprehensive regulatory information for "Weibao" Prismavrex Continuous Fluid Management and Renal Replacement Therapy Integrated System in Taiwan's medical device market through Pure Global AI's free database. is registered under number 7541c691f79e25e53533f90c5a976be7 and manufactured by GAMBRO LUNDIA AB. The authorized representative in Taiwan is BAXTER HEALTHCARE LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
7541c691f79e25e53533f90c5a976be7
Registration Details
Taiwan FDA Registration: 7541c691f79e25e53533f90c5a976be7
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

"Weibao" Prismavrex Continuous Fluid Management and Renal Replacement Therapy Integrated System
TW: "่ก›ๅฏถ" ๆ™ฎๅˆฉๅธ้ฆฌๅผ—ๅˆ—ๅ…‹ๆ–ฏ้€ฃ็บŒๆถฒ้ซ”็ฎก็†ๅŠ่…Ž่‡Ÿๆ›ฟไปฃๆฒป็™‚ๆ•ดๅˆ็ณป็ตฑ
Cancelled

Registration Details

7541c691f79e25e53533f90c5a976be7

DHA00601165201

Company Information

Sweden

Product Details

For details, it is Chinese approved copy of the imitation order

H Gastroenterology and urology

import

Dates and Status

Aug 04, 2005

Aug 04, 2015

Oct 08, 2015

Cancellation Information

Logged out

่‡ช่ซ‹่จป้Šท